openPR Logo
Press release

Pharyngitis Market Future Forecast Indicates Impressive Growth Rate

01-22-2021 07:19 AM CET | Health & Medicine

Press release from: Fact.MR

Pharyngitis Market

Pharyngitis Market

Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection. Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=361

As per the report compiled by Fact.MR, the global pharyngitis market is expected to witness sluggish growth. The market is likely to register 3.4% CAGR during the forecast period 2017-2026. The global pharyngitis market is also estimated to reach US$ 1,679.0 million revenue by the end of 2026. Pharyngitis is the most common problem among people. It is mostly caused due to other illness such as flu, cold, or mononucleosis it results in sore throat. Most of the health providers diagnose pharyngitis with the help of rapid strep test. Medicines are given by doctor only after determining whether the infection is viral or bacterial. Hence, manufacturers of drugs are conducting research to develop more effective drugs to treat pharyngitis. Below are few insights on how the global pharyngitis market will perform in the coming years.

For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=361

5 Forecast Highlights on Global Pharyngitis Market

• Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.
• North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.
• Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.
• Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.
• Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.

Get Full Access of the Report @ https://www.factmr.com/checkout/361/S

The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.

Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharyngitis Market Future Forecast Indicates Impressive Growth Rate here

News-ID: 2229438 • Views: 139

More Releases from Fact.MR

Edge Computing Market Key-Players, Growth Analysis and Forecast to 2030 | Cisc …
The global edge computing market is projected to expand with a massive 30% CAGR between the period of projection from 2020 to 2030. The Fact.MR report states that, edge computing networking technologies are rapidly gaining traction during the coronavirus pandemic as network traffic has shifted substantially from commercial infrastructure to residential infrastructure. In addition, government initiatives to track the spread of the contagion has created niche opportunities for edge computing
Refractories Market Drivers, Growth, Size and Opportunities Forecast 2020-2030 …
The refractories market is anticipated to expand with a moderate 4% CAGR during 2020 to 2030. The Fact.MR report states that the rapid rise in coronavirus cases in major iron and steel manufacturing countries such as China and India have had an adverse impact on the demand for refractory products in the short term. However, strong activity in manufacturing and construction industries will aid a strong recovery towards the end
Medical Mask Market Key Manufacturer, Industry Revenue and Gross Profit Till 20 …
Healthcare facilities around the world are preparing to keep up with the surge in coronavirus patients. Governments are highly concerned about the capabilities of existing healthcare infrastructure. Shortages of medical supplies are putting patients, doctors, and nurses at risk. The shortages of N-95 masks in particular is gaining attention owing to its importance in healthcare settings. The global medical mask market is expected to expand at an impressive 9.6% CAGR throughout
Hand Sanitizer Market Predicted to Grow at a Moderate Pace Through 2030 | Kimb …
Rising consumer inclination towards personal hygiene is driving demand for hand sanitizers amid the global COVID-19 pandemic. While outbreak driven lockdowns and stay-at-home orders initially led to panic buying and stockpiling of hand sanitizer and other hygiene products in Q1 2020, shortages and price hike were the latter repercussions. A new Fact.MR report projects a strong growth outlook for hand sanitizer market, with 1.9X expansion in revenues over 2020 -

All 5 Releases


More Releases for Pharyngitis

Pharyngitis Therapeutics Market by Source of Infection Viral and Bacterial
According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious lack of new
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and
Researchers Discover Potential of Pharyngitis Therapeutics Market
Pharyngitis Therapeutics Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Pharyngitis Therapeutics Market research report is a professional and in-depth study on the current state of Pharyngitis Therapeutics Industry. The Pharyngitis Therapeutics Market research report covers the present scenario and the growth prospects of
Pharyngitis Market Projected to Gain Significant Value by 2026
A sore throat or pharyngitis is caused when a virus infects the area of the throat. Some of the most common causes of pharyngitis is viral infections such as the influenza and common cold. Acute pharyngitis is one of the most common condition, hence, there has been an increase in demand for systematic treatment and medication. Drug manufacturers are also focusing on research and development of new drugs to treat
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis Therapeutics Market Dynamics According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious
3.4% CAGR Anticipated for Pharyngitis Market During 2017 to 2026
Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore